1. Kessler R.C., McGonagle K.C., Zhao S., Nelson C.B., Hughes M., Eshleman S., Wittchen H.-U., Kendler K.S. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch. Gen. Psychiatry, 51, 8-19.

2. Murray C.J.L., Lopez A.D. (1996). Global Burden of Disease: A Comprehensive Assessment of Mortality and Morbidity from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020, vol. 1. World Health Organization, Harvard, MA.

3. Dupont R.L., Rice D.P., Miller L.S., Shiraki S.S., Rowland C.R., Harwood H.J. (1996). Economic costs of anxiety disorders. Anxiety, 2, 167-172.

4. Greenberg P.E., Sisitsky T., Kessler R.C., Finkelstein S., Berndt E.R., Davidson J.R.T., Ballenger J.C., Fyer A.J. (1999). The economic burden of the anxiety disorders in the 1990s. J. Clin. Psychiatry, 60, 427-435.

5. Stein D.J., Hollander E. (2002). Textbook of Anxiety Disorders. American Psychiatric Press, Washington, DC.

6. Ballenger J.C., Davidson J.R., Lecrubier Y., Nutt D.J., Borkovec T.D., Stein D.J., Wittchen H.-U. (2001). Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety. J. Clin. Psychiatry, 62 (Suppl. 11), 53-58.

7. Nutt D., Rickels K., Stein D.J. (2002). Generalized Anxiety Disorder: Symptomatology, Pathogenesis, and Management. Dunitz, London.

8. Kessler R.C. (2001). The epidemiology of pure and comorbid generalized anxiety disorder. A review and evaluation of recent research. Acta Psychiatr. Scand., 406, 7-13.

9. Wittchen H.-U., Zhao S., Kessler R.C., Eaton W.W. (1994). DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. Arch. Gen. Psychiatry, 51, 355-364.

10. Stein D.J. (2001). Comorbidity in generalized anxiety disorder: impact and implications. J. Clin. Psychiatry, 62 (Suppl. 11), 29-36.

11. Stein D.J., Westenberg H., Liebowitz M.R. (2002). Social anxiety disorder and generalized anxiety disorder: serotonergic and dopaminergic neurocircuitry. J. Clin. Psychiatry, 63 (Suppl. 6), 12-19.

12. Roy-Byrne P.P., Katon W. (1997). Generalized anxiety disorder in primary care: the precursor/modifier pathway to increased health care utilization. J. Clin. Psychiatry, 58 (Suppl. 3), 34-38.

13. Behar E., Alcaine O., Zuellig A.R., Borkovec T.D. (2003). Screening for generalized anxiety disorder using the Penn State Worry Questionnaire: a receiver operating characteristic analysis. J. Behav. Ther. Exp. Psychiatry, 34, 25-43.

14. Research Unit on Pediatric Psychopharmacology Anxiety Study Group (2001). Fluvoxamine for the treatment of anxiety disorders in children and adolescents. N. Engl. J. Med., 34, 1279-1285.

15. Rynn M.A., Siqueland L., Rickels K. (2001). Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. Am. J. Psychiatry, 158, 2008-2014.

16. Stein D. J., Hollander E. (2002). Anxiety Disorders Comorbid with Depression: Social Anxiety Disorder, Post-Traumatic Stress Disorder, Generalized Anxiety Disorder and Obsessive-Compulsive Disorder. Dunitz, London.

17. Goodwin R.D., Gorman J.M. (2002). Psychopharmacologic treatment of generalized anxiety disorder and the risk of major depression. Am. J. Psychiatry, 159, 1935-1937.

18. Leckman J.F., Grice D.E., Boardman J., Zhang H., Vitale A., Bondi C., Alsobrook J., Peterson B.S., Cohen D.J., Rasmussen S.A., et al. (1997). Symptoms of obsessive-compulsive disorder. Am. J. Psychiatry, 54, 911-917.

19. Lochner C., Stein D.J. (2003). Heterogeneity of obsessive-compulsive disorder: a literature review. Harv. Rev. Psychiatry, 1l, 113-132.

20. Hollander E., Stein D.J., Broatch J., Himelein C., Rowland C. (1997). A pharmacoeconomic and quality of life study of obsessive-compulsive disorder. CNS Spectrums, 2, 16-25.

21. Seedat S., Stein D.J., Berk M., Wilson Z. (2002). Barriers to treatment among members of a mental health advocacy group in South Africa. Soc. Psychiatry Psychiatr. Epidemiol., 37, 483-487.

22. Geller D.A., Biederman J., Faraone S., Agranat A., Cradock K., Hagermose L., Frazier J., Coffey B.J. (2001). Developmental aspects of obsessive-compulsive disorder: findings in children, adolescents, and adults. J. Nerv. Ment. Dis., 189, 471-477.

23. Geller D.A., Biederman J., Stewart S.E., Mullin B., Martin A., Spencer T. (2003). Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. Am. J. Psychiatry, 160, 1919-1928.

24. Swedo S.E., Leonard H.L., Garvey M., Mittleman B., Allen A.J., Perlmutter S., Lougee L., Dow S., Zamkoff J., Dubbert B.K., et al. (1998). Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am. J. Psychiatry, 155, 264-271.

25. Garvey MA., Perlmutter S.J., Allen A.J., Hamburger S., Lougee L., Leonard H.L., Witowski M.E., Dubbert B., Swedo S.E. (1999). A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol. Psychiatry, 45, 1564-1571.

26. Neziroglu F., Anemone R., Yaryura-Tobias J.A. (1992). Onset of obsessive-compulsive disorder in pregnancy. Am. J. Psychiatry, 1490, 947-950.

27. Ozaki N., Goldman D., Kaye W.H., Plotnicov K., Greenberg B.D., Lappalainen J., Rudnick G., Murphy D.L. (2003). Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype. Mol. Psychiatry, 8, 895, 933-936.

28. Roy-Byrne P.P., Stang P., Wittchen H.-U., Ustun B., Walters E.E., Kessler R.C. (2000). Lifetime panic-depression comorbidity in the National Comorbidity Survey: association with symptoms, impairment, course and help-seeking. Br. J. Psychiatry, 176, 229-235.

29. Gorman J.M., Kent J.M., Sullivan G.M., Coplan J.D. (2000). Neuroanatomical hypothesis of panic disorder, revised. Am. J. Psychiatry, 157 493-505.

30. Yonkers K.A., Bruce S.E., Dyck I.R., Keller M.B. (2003). Chronicity, relapse, and illness - course of panic disorder, social phobia, and generalized anxiety disorder: findings in men and women from 8 years of follow-up. Depress. Anxiety, 17, 173-179.

31. McNally R.J. (2002). Anxiety sensitivity and panic disorder. Biol. Psychiatry, 52, 938-946.

32. Klein D.F. (1993). False suffocation alarms, spontaneous panics, and related conditions: an integrative hypothesis. Arch. Gen. Psychiatry, 50, 306-317.

33. Goodwin R.D. (2003). Asthma and anxiety disorders. Adv. Psychosom. Med., 24, 51-71.

34. Isensee B., Wittchen H.-U., Stein M.B., Hofler M., Lieb R. (2003). Smoking increases the risk of panic: findings from a prospective community study. Arch. Gen. Psychiatry, 60, 692-700.

35. Goodwin R., Olfson M. (2001). Treatment of panic attack and risk of major depression in the community. Am. J. Psychiatry, 158, 1146-1148.

36. Yehuda R., McFarlane A.C. (1995). Conflict between current knowledge about posttraumatic stress disorder and its original conceptual basis. Am. J. Psychiatry, 152, 1705-1713.

37. Kessler R.C., Sonnega A., Bromet E., Hughes M., Nelson C.B. (1995). Posttraumatic stress disorder in the National Comorbidity Survey. Arch. Gen. Psychiatry, 52, 1048-1060.

38. Kessler R.C. (2002). Posttraumatic stress disorder: the burden to the individual and to society. J. Clin. Psychiatry, 61 (Suppl. 5), 4-12.

39. Seedat S., Kaminer D., Lockhat S., Stein D.J. (2000). An overview of posttraumatic stress disorder in children and adolescents. Primary Care Psychiatry, 6, 43-48.

40. Seedat S., Stein D.J. (2000). Trauma and post-traumatic stress disorder in women: a review. Int. Clin. Psychopharmacol., 15 (Suppl. 3), 25-34.

41. Ballenger J.C., Davidson J.R., Lecrubier Y., Nutt D.J., Foa E.B., Kessler R.C., McFarlane A.C., Shalev A.Y. (2000). Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety. J. Clin. Psychiatry, 61 (Suppl. 5), 60-66.

42. Muris P., Merckelbach H., Korver P., Meesters C. (2000). Screening for trauma in children and adolescents: the validity of the Traumatic Stress Disorder Scale for the screen for child anxiety related emotional disorders. J. Clin. Child Psychol., 29, 406-413.

43. Coker A.L., Pope B.O., Smith P.H., Sanderson M., Hussey J.R. (2001). Assessment of clinical partner violence screening tools. J. Am. Med. Women's Assoc., 56,19-23.

44. Brewin C.R., Andrews B., Valentine J.D. (2000). Meta-analysis of risk factors for posttraumatic stress disorder in trauma-exposed adults. J. Consult. Clin. Psychol., 68, 748-766.

45. Yehuda R. (2004). Risk and resilience in posttraumatic stress disorder. J. Clin. Psychiatry, 65 (Suppl. 1), 29-36.

46. Brewin C.R., Rose S., Andrews A., Green J., Tata P., McEvedy C., Turner S., Foa E.B. (2002). Brief screening instrument for post-traumatic stress disorder. Br. J. Psychiatry, 181, 158-162.

47. Stallard P., Velleman R., Baldwin S. (1999). Psychological screening of children for post-traumatic stress disorder. J. Child Psychol. Psychiatry, 40, 1075-1082.

48. Silove D., Blaszczynski A., Manicavasager V., Tyndall K., Petridis A., Hillman K. (2003). Capacity of screening questionnaires to predict psychiatric morbidity 18 months after motor vehicle accidents. J. Nerv. Ment. Dis., 191, 604-610.

49. Rose S., Bisson J., Wessely S. (2003). A systematic review of single-session psychological interventions ("debriefing") following trauma. Psychother. Psychosom., 72, 176-184.

50. Esterling B.A., L'Abate L., Murray E.J., Pennebaker J.W. (1999). Empirical foundations for writing in prevention and psychotherapy: mental and physical health outcomes. Clin. Psychol. Rev., 19, 79-96.

51. Bryant R., Harvey A., Dang S., Sackville T., Basten C. (1998). Treatment of acute stress disorder: a comparison of cognitive-behavioral therapy and supportive counseling. J. Consult. Clin. Psychol., 66, 862-866.

52. Gidron Y., Gal R., Freedman S., Twiser I., Lauden A., Snir Y., Benjamin J. (2001). Translating research findings to PTSD prevention: results of a randomized-controlled pilot study. J. Trauma. Stress, 14, 773-780.

53. Pitman R.K., Sanders K.M., Zusman R.M., Healy A.R., Cheema F., Lasko N.B., Cahill L., Orr S.P. (2002). Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol. Psychiatry, 51, 189-192.

54. Vaiva G., Ducrocq F., Jezequel K., Averland B., Lestavel P., Brunet A., Marmar C.R. (2003). Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma. Biol. Psychiatry, 54, 947-949.

55. Robert R., Blakeney P.E., Villarreal C., Rosenberg L., Meyer W.J. III (1999). Imipramine treatment in pediatric burn patients with symptoms of acute stress disorder: a pilot study. J. Am. Acad. Child Adolesc. Psychiatry, 38, 873-882.

56. Gelpin E., Bonne E., Peri T., Brandes D., Shalev A.Y. (1996). Treatment of recent trauma survivors with benzodiazepines: a prospective study. J. Clin. Psychiatry, 57, 390-394.

57. Miller Brotman L., Gouley K.K., Klein R.G., Castellanos F.X., Pine D.S. (2003). Children, stress, and context: integrating basic, clinical, and experimental prevention research. Child Develop., 74, 1053-1057.

58. Fisher P.A., Gunnar M.R., Chamberlain P., Reid J.G. (2000). Preventive intervention for maltreated preschool children: impact on children's behavior, neuroendocrine activity, and foster parent functioning. Am. Acad. Child Adolesc. Psychiatry, 39, 1356-1364.

59. Magee W.J., Eaton W.W., Wittchen H.-U., McGonagle K.A., Kessler R.C. (1996). Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey. Arch. Gen. Psychiatry, 53, 159-168.

60. Lochner C., Mogotsi M., du Toit P.L., Kaminer D., Niehaus D.J., Stein D.J. (2003). Quality of life in the anxiety disorders: a comparison of obsessive-compulsive disorder, social anxiety disorder, and panic disorder. Psycho-pathology, 36, 255-262.

61. Kessler R.C., Stang P., Wittchen H.-U., Stein M., Walters E.E. (1999). Lifetime co-morbidities between social phobia and mood disorders in the US National Comorbidity Survey. Psychol. Med., 29, 555-567.

62. Ballenger J.C., Davidson J.A., Lecrubier Y., Nutt D.J., Bobes J., Beidel D.C., Ono Y., Westenberg H.G. (1998). Consensus statement on social anxiety disorder from the international consensus group on depression and anxiety. J. Clin. Psychiatry, 59, 54-60.

63. Connor K.M., Kobak K.A., Churchill L.E., Katzelnick D., Davidson J.R. (2001). Mini-SPIN: a brief screening assessment for generalized social anxiety disorder. Depress. Anxiety, 14, 137-140.

64. Mennin D.S., Fresco D.M., Heimberg R.G., Schneier F.R., Davies S.O., Liebowitz M.R. (2002). Screening for social anxiety disorder in the clinical setting: using the Liebowitz Social Anxiety Scale. J. Anxiety Disord., 16, 661-673.

65. Hettema J.M., Neale M.C., Kendler K.S. (2001). A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am. J. Psychiatry, 158,1568-1578.

66. Kagan J., Reznick J.S., Snidman N. (1987). The physiology and psychology of behavioral inhibition in children. Child Develop., 58, 1459-1473.

67. Rapee R.M. (2002). The development and modification of temperamental risk for anxiety disorders: prevention of a lifetime of anxiety? Biol. Psychiatry, 52, 947-957.

68. Kagan J., Reznick S., Snidman N. (1988). Biological bases of childhood shyness. Science, 240, 167-171.

69. Smoller J.W., Rosenbaum J.F., Biederman J., Kennedy J., Dai D., Racette S.R., Laird N.M., Kagan J., Snidman N., Hirshfeld-Becker D., et al. (2003). Association of a genetic marker at the corticotropin-releasing hormone locus with behavioral inhibition. Biol. Psychiatry, 54,1376-1381.

70. Schwartz C.E., Wright C.I., Shin L.M., Kagan J., Rauch S.L. (2003). Inhibited and uninhibited infants ''grown up'': adult amygdalar response to novelty. Science, 5627, 1952-1953.

71. Kagan J., Snidman N. (1999). Early childhood predictors of adult anxiety disorders. Biol. Psychiatry, 46, 1536-1541.

72. Schwartz C.E., Snidman N., Kagan J. (1999). Adolescent social anxiety as an outcome of inhibited temperament in childhood. J. Am. Acad. Child Adolesc. Psychiatry, 38, 1008-1015.

73. Donovan C.L., Spence S.H. (2000). Prevention of childhood anxiety disorders. Clin. Psychol. Rev., 2G, 509-531.

74. Kirmayer L.J., Robbins J.M., Dworkind M., Yaffe M.J. (1993). Somatization and the recognition of depression and anxiety in primary care. Am. J. Psychiatry, lSG, 734-741.

75. Sherbourne C.D., Wells K.B., Meredith L.S., Jackson C.A., Camp P. (1996). Comorbid anxiety disorder and the functioning and well-being of chronically ill patients of general medical providers. Arch. Gen. Psychiatry, S3, 889-895.

76. Young A.S., Klap R., Sherbourne C.D., Wells K.B. (2001). The quality of care for depressive and anxiety disorders in the United States. Arch. Gen. Psychiatry, 58, 55-61.

77. Wang P.S., Demler O., Kessler R.C. (2002). Adequacy of treatment for serious mental illness in the United States. Am. J. Public Health, 92, 92-98.

78. Leon A.C., Olfson M., Broadhead W.E., Barrett J.E., Blacklow R.S., Keller M.B., Higgins E.S., Weissman W.W. (1995). Prevalence of mental disorders in primary care. Implications for screening. Arch. Fam. Med., 4, 857-861.

79. Kessler D., Bennewith O., Lewis G., Sharp D. (2002). Detection of depression and anxiety in primary care: follow-up study. Br. Med. J., 32S, 1016-1017.

80. Lang A.J., Stein M.B. (2002). Screening for anxiety in primary care: why bother? Gen. Hosp. Psychiatry, 24, 365-366.

81. Ritsher J.B., Struening E.L., Hellman F., Guardino M. (2002). Internal validity of an anxiety disorder screening instrument across five ethnic groups. Psychiatry Res., lll, 199-213.

82. Gilbody S.M., House A.O., Sheldon T.A. (2001). Routinely administered questionnaires for depression and anxiety: systematic review. Br. Med. J., 322, 406-409.

83. Sinoff G., Ore L., Zlotogorsky D., Tamir A. (1999). Short Anxiety Screening Test - a brief instrument for detecting anxiety in the elderly. Int. J. Geriatr. Psychiatry, l4, 1062-1071.

84. Lee D.T., Wong C.K., Ungvari G.S., Cheung L.P., Haines C.J., Chung T.K. (1997). Screening psychiatric morbidity after miscarriage: application of the 30-item General Health Questionnaire and the Edinburgh Postnatal Depression Scale. Psychosom. Med., 59, 207-210.

85. Davis T.M., Ross C.J., MacDonald G.F. (2002). Screening and assessing adult asthmatics for anxiety disorders. Clin. Nurs. Res., 11, 173-189.

86. Dierker L.C., Albano A.M., Clarke G.N., Heimberg R.G., Kendall P.C., Merikangas K.R., Lewinsohn P.M., Offord D.R., Kessler R.C. (2001). Screening for anxiety and depression in early adolescence. J. Am. Acad. Child Adolesc. Psychiatry, 4G, 929-936.

87. Weisberg R.B., Paquette J.A. (2002). Screening and treatment of anxiety disorders in pregnant and lactating women. Women's Health Issues, 12, 32-36.

88. Harter M., Reuter K., Gross-Hardt K., Bengel J. (2001). Screening for anxiety, depressive and somatoform disorders in rehabilitation - validity of HADS and GHQ-12 in patients with musculoskeletal disease. Disabil. Rehabil., 23, 737-744.

89. Franken I.H., Hendriks V.M. (2001). Screening and diagnosis of anxiety and mood disorders in substance abuse patients. Am. J. Addict., 10, 30-39.

90. El-Rufaie O.E., Absood G.H., Abou-Saleh M.T. (1997). The primary care anxiety and depression (PCAD) scale: a culture-oriented screening scale. Acta Psychiatr. Scand., 95, 119-124.

91. Le Fevre P., Devereux J., Smith S., Lawrie S.M., Cornbleet M. (1999). Screening for psychiatric illness in the palliative care inpatient setting: a comparison between the Hospital Anxiety and Depression Scale and the General Health Questionnaire-12. Palliat. Med., 13, 399-407.

92. Muzik M., Klier C.M., Rosenblum K.L., Holzinger A., Umek W., Katschnig H. (2000). Are commonly used self-report inventories suitable for screening postpartum depression and anxiety disorders? Acta Psychiatr. Scand., 102, 71-73.

93. Payne D.K., Hoffman R.G., Theodoulou M., Dosik M., Massie M.J. (1999). Screening for anxiety and depression in women with breast cancer. Psychiatry and medical oncology gear up for managed care. Psychosomatics, 40, 64-69.

94. Wittchen H.U., Boyer P. (1998). Screening for anxiety disorders. Sensitivity and specificity of the Anxiety Screening Questionnaire (ASQ-15). Br. J. Psychiatry, 34S, 10-17.

95. Goldberg D.P., Rickels K., Downing R., Hesbacher P. (1976). A comparison of two psychiatric screening tests. Br. J. Psychiatry, 129, 61-67.

96. Kessler R.C., Andrews G., Colpe L.J., Hiripi E., Mroczek D.K., Normand S.L., Walters E.E., Zaslavsky A.M. (2002). Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol. Med., 32, 959-976.

97. Lloyd-Williams M., Friedman T., Rudd N. (2001). An analysis of the validity of the Hospital Anxiety and Depression scale as a screening tool in patients with advanced metastatic cancer. J. Pain Symptom Manage., 22, 990-996.

98. Goldberg D., Huxley P. (1992). Common Mental Disorders. Routledge, London.

99. Wildner M. (2003). Health economic issues of screening programmes. Eur. J. Pediatr., 162 (Suppl. 1), 5-7.

100. Lewis G., Sharp D., Bartholomew J., Pelosi A.J. (1996). Computerized assessment of common mental disorders in primary care: effect on clinical outcome. Fam. Pract., 13, 120-126.

101. Farvolden P., McBride C., Bagby R.M., Ravitz P. (2003). A web-based screening instrument for depression and anxiety disorders in primary care. J. Med. Internet Res. 5, 23.

102. Stein M.B., Chartier M.J., Hazen A.L., Kozak M.V., Tancher M.E., Lander S., Furer P., Chubaty D., Walker J.R. (1998). A direct-interview family study of generalized social phobia. Am. J. Psychiatry, 155, 90-97.

103. Andrews G., Wilkinson D.D. (2002). The prevention of mental disorders in young people. Med. J. Australia, 177S, 97-100.

104. Mrazek P.J., Haggerty R.J. (1994). Reducing the Risks for Mental Disorders: Frontiers for Preventive Intervention Research. National Academy Press, Washington, DC.

105. Lowry-Webster H., Barrett P.M., Dadds M.R. (2001). A universal prevention trial of anxiety and depressive symptomatology in childhood: preliminary data from an Australian study. Behav. Change, 18, 36-50.

106. Barrett P., Turner C. (2001). Prevention of anxiety symptoms in primary school children: preliminary results from a universal school-based trial. Br. J. Clin. Psychol., 40, 399-410.

107. Leighton A.H., Murphy J.M. (1987). Primary prevention of psychiatric disorders. Acta Psychiatr. Scand., 337S, 7-22.

108. Short J.L. (1998). Evaluation of a substance abuse prevention and mental health promotion program for children of divorce. J. Divorce Remarriage, 28, 139-155.

109. Felner R.D., Adan A.M. (1988). The School Transition Environment Project: an ecological intervention and evaluation. In: Price R.H., Cowen E.L., Lorion R.P., Ramos-McKay J. (eds) Fourteen Ounces of Prevention: A Case Book for Practitioners. American Psychological Association, Washington, DC, pp. 111-122.

110. Klingman A. (1985). Mass inoculation in a community: the effect of primary prevention of stress reactions. Am. J. Commun. Psychol., 13, 323-332.

111. Weinstein P. (1990). Breaking the worldwide cycle of pain, fear and avoidance: uncovering risk factors and promoting prevention for children. Ann. Behav. Med., 12, 141-147.

112. Tyron G.S. (1980). The measurement and treatment of test anxiety. Rev. Educat. Res., 50, 343-372.

113. Hovey J.D., Magana C.G. (2002). Psychosocial predictors of anxiety among immigrant Mexican migrant farmworkers: implications for prevention and treatment. Cultur. Divers. Ethnic Minor. Psychol., 8, 274-289.

114. Marshall K.G. (1996). Prevention. How much harm? How much benefit? 3. Physical, psychological and social harm. Can. Med. Ass. J., 155, 169-176.

115. LaFreniere P.J., Capuano F. (1997). Preventive intervention as means of clarifying direction of effects in socialization: anxious-withdrawn preschoolers case. Develop. Psychopathol., 9, 551-564.

116. Dadds M.R., Holland D.E., Laurens K.R., Mullins M., Barrett P.M., Spence S.H. (1999). Prevention and early intervention for anxiety disorders: a controlled trial. J. Consult. Clin. Psychol., 67, 145-150.

117. Holahan C.J., Richardson F.C., Puckett S.P., Bell K.F. (2004). Evaluation of two test-anxiety reduction treatments in a secondary prevention program. Am. J. Commun. Psychol., 7, 679-687.

118. Richardson G.E. (2002). The metatheory of resilience and resiliency. J. Clin. Psychol., 58, 307-321.

119. Stein D.J., Wessels C., Zungu-Dirwayi N., Berk M., Wilson Z. (2001). Value and effectiveness of consumer advocacy groups: a survey of the anxiety disorders support group in South Africa. Depress. Anxiety, 13, 105-107.

120. Christiana J.M., Gilman S.E., Guardino M., Michelson K., Morselli P.L., Olfson M., Kessler R.C. (2000). Duration between onset and time of obtaining initial treatment among people with anxiety and mood disorders: an international survey of members of mental health patient advocate groups. Psychol. Med., 30, 693-703.

121. Kessler R.C., Olfson M., Berglund P.A. (1998). Patterns and predictors of treatment contact after first onset of psychiatric disorders. Am. J. Psychiatry, 155, 62-69.

122. Weisz J.R., Weiss B. (1991). Studying the "referability" of child clinical problems. J. Consult. Clin. Psychol., 59, 266-273.

123. Polyrev T., Weinstock M. (2004). Gender difference in the prevention of hyperanxiety in adult prenatally stressed rats by chronic treatment with amitriptyline. Psychopharmacology, 171, 270-276.

Anxiety and Depression 101

Anxiety and Depression 101

Everything you ever wanted to know about. We have been discussing depression and anxiety and how different information that is out on the market only seems to target one particular cure for these two common conditions that seem to walk hand in hand.

Get My Free Ebook

Post a comment